(Q31799450)

3 July 2017

title

A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence (English)

1 reference

3 July 2017

0 references

0 references

1 reference

Cornish JW

1

1 reference

3 July 2017

Maany I

2

1 reference

3 July 2017

Fudala PJ

3

1 reference

3 July 2017

Ehrman RN

4

1 reference

3 July 2017

Robbins SJ

5

1 reference

3 July 2017

O'Brien CP

6

1 reference

3 July 2017

publication date

1 January 2001

1 reference

Drug and Alcohol Dependence

3 July 2017

published in

1 reference

3 July 2017

volume

61

1 reference

3 July 2017

issue

2

1 reference

3 July 2017

page(s)

183-189

1 reference

Effects of repeated ritanserin on middle-aged poor sleepers

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Serotonergic mechanisms of cocaine effects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Failure of ritanserin to block cocaine cue reactivity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Ritanserin in the treatment of cocaine dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Ritanserin Reduces Abuse of Alcohol, Cocaine, and Fentanyl in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

The effects of ritanserin on mood and sleep in abstinent alcoholic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Effects of ritanserin on sleep disturbances of dysthymic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Tryptophan depletion and attenuation of cue-induced craving for cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

A Structured Interview Guide for the Hamilton Depression Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

Pharmacotherapy of cocaine abuse: preclinical development

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900140-X

7 January 2021

10.1016/S0376-8716(00)00140-X

Identifiers

DOI

1 reference

3 July 2017

1 reference